Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review

被引：40

作者：

Calderon-Martinez, Evelyn ^{[1
]}

Landazuri-Navas, Samanta ^{[2
]}

Vilchez, Esmeralda ^{[3
]}

Cantu-Hernandez, Raul ^{[4
]}

Mosquera-Moscoso, Johanna ^{[2
]}

Encalada, Sebastian ^{[2
]}

Al lami, Zahraa ^{[5
]}

Zevallos-Delgado, Christian ^{[6
]}

Cinicola, John ^{[1
]}

机构：

[1] UPMC Harrisburg, Dept Internal Med, Harrisburg, PA 17104 USA

[2] Univ Amer, Dept Internal Med, Quito, Ecuador

[3] Univ Guadalajara, Dept Internal Med, Guadalajara, Jalisco, Mexico

[4] Monterrey Inst Technol & Higher Studies, Dept Internal Med, Monterrey, Nuevo Leon, Mexico

[5] Univ Baghdad, Coll Med, Dept Internal Med, Baghdad, Iraq

[6] Univ Houston, Dept Biomed Engn, Houston, TX USA

来源：

JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA | 2023年 / 15卷 / 04期

关键词：

Cancer; Hepatocellular; Survival; Mortality; HUMAN-IMMUNODEFICIENCY-VIRUS; STAGING SYSTEMS; HEPATITIS-B; EPIDEMIOLOGY; SURVEILLANCE; CANCER; VALIDATION; MANAGEMENT; NASH;

D O I：

10.14740/jocmr4902

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatocellular carcinoma (HCC) is a common cancer and ranks sixth among all malignancies worldwide. Risk factors for HCC can be classified as infectious or behavioral. Viral hepatitis and alcohol abuse are currently the most common risk factors for HCC; however, non-alcoholic liver disease is expected to become the most common cause of HCC in upcoming years. HCC survival rates vary according to the causative risk factors. As in any malignancy, staging is crucial in making therapeutic decisions. The selection of a specific score should be individualized according to patient characteristics. In this review, we summarize the current data on epidemiology, risk factors, prognostic scores, and survival in HCC.

引用

页码：200 / 207

页数：8

共 68 条

[1]

Abudeif A., 2019, Sohag Med. J, V23, P8, DOI [10.21608/smj.2019.13376.1019, DOI 10.21608/SMJ.2019.13376.1019]

[2] The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].

Akinyemiju, Tomi ;

Abera, Semaw ;

Ahmed, Muktar ;

Alam, Noore ;

Alemayohu, Mulubirhan Assefa ;

Allen, Christine ;

Al-Raddadi, Rajaa ;

Alvis-Guzman, Nelson ;

Amoako, Yaw ;

Artaman, Al ;

Ayele, Tadesse Awoke ;

Barac, Aleksandra ;

Bensenor, Isabela ;

Berhane, Adugnaw ;

Bhutta, Zulfiqar ;

Castillo-Rivas, Jacqueline ;

Chitheer, Abdulaal ;

Choi, Jee-Young ;

Cowie, Benjamin ;

Dandona, Lalit ;

Dandona, Rakhi ;

Dey, Subhojit ;

Dicker, Daniel ;

Phuc, Huyen ;

Ekwueme, Donatus U. ;

Zaki, Maysaa El Sayed ;

Fischer, Florian ;

Furst, Thomas ;

Hancock, Jamie ;

Hay, Simon I. ;

Hotez, Peter ;

Jee, Sun Ha ;

Kasaeian, Amir ;

Khader, Yousef ;

Khang, Young-Ho ;

Kumar, G. Anil ;

Kutz, Michael ;

Larson, Heidi ;

Lopez, Alan ;

Lunevicius, Raimundas ;

Malekzadeh, Reza ;

McAlinden, Colm ;

Meier, Toni ;

Mendoza, Walter ;

Mokdad, Ali ;

Moradi-Lakeh, Maziar ;

Nagel, Gabriele ;

Nguyen, Quyen ;

Nguyen, Grant ;

Ogbo, Felix .

JAMA ONCOLOGY, 2017, 3 (12) :1683-1691

[3] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].

Amin, Mahul B. ;

Greene, Frederick L. ;

Edge, Stephen B. ;

Compton, Carolyn C. ;

Gershenwald, Jeffrey E. ;

Brookland, Robert K. ;

Meyer, Laura ;

Gress, Donna M. ;

Byrd, David R. ;

Winchester, David P. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99

[4] From NASH to HCC: current concepts and future challenges [J].

Anstee, Quentin M. ;

Reeves, Helen L. ;

Kotsiliti, Elena ;

Govaere, Olivier ;

Heikenwalder, Mathias .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (07) :411-428

[5]

Baecker A, 2018, EUR J CANCER PREV, V27, P205, DOI [10.1097/CEJ.0000000000000428, 10.1097/cej.0000000000000428]

[6] Hepatocellular carcinoma: a review [J].

Balogh, Julius ;

Victor, David, III ;

Asham, Emad H. ;

Burroughs, Sherilyn Gordon ;

Boktour, Maha ;

Saharia, Ashish ;

Li, Xian ;

Ghobrial, R. Mark ;

Monsour, Howard P., Jr. .

JOURNAL OF HEPATOCELLULAR CARCINOMA, 2016, 3 :41-53

[7] Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis [J].

Brar, Gagandeep ;

Greten, Tim F. ;

Graubard, Barry, I ;

McNeel, Timothy S. ;

Petrick, Jessica L. ;

McGlynn, Katherine A. ;

Altekruse, Sean F. .

HEPATOLOGY COMMUNICATIONS, 2020, 4 (10) :1541-1551

[8] Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018) [J].

Bray, F. ;

Ferlay, J. ;

Soerjomataram, I ;

Siegel, R. L. ;

Torre, L. A. ;

Jemal, A. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (04) :313-313

[9] Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome [J].

Bucci, L. ;

Garuti, F. ;

Camelli, V. ;

Lenzi, B. ;

Farinati, F. ;

Giannini, E. G. ;

Ciccarese, F. ;

Piscaglia, F. ;

Rapaccini, G. L. ;

Di Marco, M. ;

Caturelli, E. ;

Zoli, M. ;

Borzio, F. ;

Sacco, R. ;

Maida, M. ;

Felder, M. ;

Morisco, F. ;

Gasbarrini, A. ;

Gemini, S. ;

Foschi, F. G. ;

Missale, G. ;

Masotto, A. ;

Affronti, A. ;

Bernardi, M. ;

Trevisani, F. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (03) :385-399

[10] Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma [J].

Chen, Li-Ju ;

Chang, Yun-Jau ;

Chang, Yao-Jen .

ONCOLOGIST, 2021, 26 (03) :E445-E453

← 1 2 3 4 5 6 7 →